LERONET Trademark

Trademark Overview

On Monday, November 22, 2010, a trademark application was filed for LERONET with the United States Patent and Trademark Office. The USPTO has given the LERONET trademark a serial number of 85182439. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 7, 2014. This trademark is owned by Glaxo Group Limited. The LERONET trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
leronet

General Information

Serial Number85182439
Word MarkLERONET
Filing DateMonday, November 22, 2010
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 7, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 5, 2011

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, November 26, 2010
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Monday, July 7, 2014ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, July 7, 2014ABANDONMENT - NO USE STATEMENT FILED
Thursday, December 5, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 4, 2013EXTENSION 5 GRANTED
Thursday, November 21, 2013EXTENSION 5 FILED
Thursday, November 21, 2013TEAS EXTENSION RECEIVED
Tuesday, May 14, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 13, 2013EXTENSION 4 GRANTED
Thursday, April 18, 2013EXTENSION 4 FILED
Friday, May 10, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, April 18, 2013TEAS EXTENSION RECEIVED
Monday, March 25, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 25, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, March 25, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 25, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 21, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 20, 2012EXTENSION 3 GRANTED
Friday, November 16, 2012EXTENSION 3 FILED
Friday, November 16, 2012TEAS EXTENSION RECEIVED
Wednesday, June 13, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 12, 2012EXTENSION 2 GRANTED
Wednesday, May 16, 2012EXTENSION 2 FILED
Tuesday, June 12, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, May 16, 2012TEAS EXTENSION RECEIVED
Tuesday, November 8, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 4, 2011EXTENSION 1 GRANTED
Friday, November 4, 2011EXTENSION 1 FILED
Friday, November 4, 2011TEAS EXTENSION RECEIVED
Tuesday, May 31, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 5, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 5, 2011PUBLISHED FOR OPPOSITION
Saturday, February 26, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, February 26, 2011ASSIGNED TO EXAMINER
Friday, November 26, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, November 25, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

leronet pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological